Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Auto and Transport Industry News Why did Viking Cruises launch a $1.7 billion private senior notes offering and what does it mean for investors? Viking Cruises launches $1.7B senior notes to refinance debt and leases. See how this move reshapes its balance sheet, stock sentiment, and growth outlook. byShanvithaSeptember 29, 2025